Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Total Current Liabilities (2016 - 2025)

Biomerica's Total Current Liabilities history spans 15 years, with the latest figure at $1.6 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 14.77% year-over-year to $1.6 million; the TTM value through Nov 2025 reached $1.6 million, down 14.77%, while the annual FY2025 figure was $1.7 million, 21.05% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $1.6 million at Biomerica, down from $1.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $6.7 million in Q1 2022 and bottomed at $1.3 million in Q2 2021.
  • The 5-year median for Total Current Liabilities is $1.8 million (2022), against an average of $2.1 million.
  • The largest annual shift saw Total Current Liabilities surged 395.41% in 2022 before it crashed 79.17% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $4.7 million in 2021, then plummeted by 62.81% to $1.8 million in 2022, then increased by 3.33% to $1.8 million in 2023, then increased by 2.96% to $1.9 million in 2024, then dropped by 14.77% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Total Current Liabilities are $1.6 million (Q4 2025), $1.7 million (Q3 2025), and $1.7 million (Q2 2025).